Absolute Antibody's Merger

Absolute Antibody raised a round of funding on February 12, 2018. Investors include Kerafast.

Absolute Antibody has developed a manufacturing platform based on transient transfection for the production of sequenced and engineered antibodies, AbsoluteAbs (AbAbs). These engineered antibodies pro…

Articles about Absolute Antibody's Merger: